These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6078445)

  • 1. [Evaluation of the effectiveness of anti-mumps vaccination by means of hemagglutination inhibition tests, using blood collected on filter paper disks].
    Copelovici Y; Strati I; Strulovici D; Mendel A; Băişan I
    Stud Cercet Inframicrobiol; 1967; 18(3):187-90. PubMed ID: 6078445
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-mumps vaccination with live attenuated vaccine in a children's community].
    Drouhet V; Celers J; Minvielle A; Lévy-Thierry S
    Ann Pediatr (Paris); 1971 Apr; 18(4):277-85. PubMed ID: 5574000
    [No Abstract]   [Full Text] [Related]  

  • 3. Experiences with Jeryl Lynn strain live attenuated mumps virus vaccine in a pediatric outpatient clinic.
    Young ML; Dickstein B; Weibel RE; Stokes J; Buynak EB; Hilleman MR
    Pediatrics; 1967 Nov; 40(5):798-803. PubMed ID: 6075651
    [No Abstract]   [Full Text] [Related]  

  • 4. Live attenuated mumps virus vaccine. II. Early clinical studies.
    Stokes J; Weibel RE; Buynak EB; Hilleman MR
    Pediatrics; 1967 Mar; 39(3):363-71. PubMed ID: 6018966
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serodiagnosis of mumps virus infections].
    Spencker FB; Horn M; Sandow D; Keller HP
    Z Gesamte Inn Med; 1970 Nov; 25(21):981-6. PubMed ID: 5523031
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of mumps vaccine given after exposure to mumps, with special reference to the exposed adult.
    Meyer MB; Stifler WC; Joseph JM
    Pediatrics; 1966 Feb; 37(2):304-15. PubMed ID: 5902092
    [No Abstract]   [Full Text] [Related]  

  • 7. [Seroepidemiologic study in Morocco. Immunologic survey on mumps (study of hemagglutination inhibition antibodies of mumps virus in 975 serums)].
    Sebti N; Alaoui A; Amkadmi A
    Maghrib Tibbi; 1980 Dec; 2(4):407-17. PubMed ID: 7345233
    [No Abstract]   [Full Text] [Related]  

  • 8. [Spontaneously acquired anti-mumps immunity in children and adults].
    Drouhet V; Celers J
    Ann Pediatr (Paris); 1971 Apr; 18(4):272-6. PubMed ID: 5573999
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of mumps infection. Laboratory studies and their value for confirmation of the disease and the detection of clinically atypical forms].
    Drouhet V; Celers J; Richard JJ
    Ann Pediatr (Paris); 1971 Apr; 18(4):263-71. PubMed ID: 5573998
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serological studies of mumps vaccination].
    Zalman MW; Elias A; Bradin ZL; Pelle A; Ghimiş L; Ioţcovici S; Tavie A
    Stud Cercet Inframicrobiol; 1965; 16(2):129-33. PubMed ID: 5829061
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mumps and diabetes].
    Celers J; Drouhet V; Lévy-Thierry S; Deschamps I; Besse J; Lestradet H
    Ann Pediatr (Paris); 1971 Apr; 18(4):306-13. PubMed ID: 5574002
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of cellular immunity to mumps in vaccinated individuals with or without circulating antibodies up to 16 years after their last vaccination.
    Vandermeulen C; Clement F; Roelants M; Van Damme P; Hoppenbrouwers K; Leroux-Roels G
    J Infect Dis; 2009 May; 199(10):1457-60. PubMed ID: 19320590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of hemagglutination-inhibiting antibodies against mumps virus in normal individuals of Accra (Ghana)].
    Russo V; Darrigo C; Rosei L
    Arch Ital Sci Med Trop Parassitol; 1968; 49(7):229-33. PubMed ID: 5715935
    [No Abstract]   [Full Text] [Related]  

  • 14. Mumps, mumps vaccination, islet cell antibodies and the first manifestation of diabetes mellitus type I.
    Otten A; Helmke K; Stief T; Mueller-Eckhard G; Willems WR; Federlin K
    Behring Inst Mitt; 1984 Jul; (75):83-8. PubMed ID: 6385957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of the primary and secondary antibody responses to myxoviruses.
    Heffner RR; Schluederberg A
    J Immunol; 1967 Apr; 98(4):668-72. PubMed ID: 4960650
    [No Abstract]   [Full Text] [Related]  

  • 16. [INVESTIGATION OF THE HEMAGGLUTINATION INHIBITION ANTIBODIES OF EPIDEMIC PAROTITIS VIRUS IN PERSONS OF DIFFERENT AGES].
    SOSA MARTINEZ J; LIRAYDELMAZO MS; DURANVIDAURRI M; BENAVIDES L
    Bol Med Hosp Infant Mex; 1964; 21():330-7. PubMed ID: 14180455
    [No Abstract]   [Full Text] [Related]  

  • 17. Measles vaccination. Serologic response and persistence of antibody titer by age at vaccination.
    Biberi-Moroeanu S; Munţiu A; Tiţeica M
    Arch Roum Pathol Exp Microbiol; 1982; 41(4):347-55. PubMed ID: 7171306
    [No Abstract]   [Full Text] [Related]  

  • 18. [Community effectiveness of vaccines against infectious parotiditis (mumps). Report of cases].
    Limón Mora J; Molina López T; Domínguez Camacho JC
    Rev Esp Salud Publica; 1999; 73(4):455-64. PubMed ID: 10575934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acquisition of delayed hypersensitivity following attenuated mumps virus infection.
    Horowitz SD; Nagatani MS; Bowen GS; Holloway AW; St Geme JW
    Pediatrics; 1970 Jan; 45(1):77-82. PubMed ID: 5410253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.